Condition

Metastatic Gastric Cancer clinical trials and research

• 12Clinical trials
• 13Countries

Newest Metastatic Gastric Cancer clinical trials

All recruiting trials (12)

• Maintenance therapy in metastatic gastric cancer: a multicenter look from Colombia

  This study reviews medical records of adults with metastatic gastric cancer in Colombia to see how patients fare after starting maintenance therapy following initial chemotherapy.

  Recruiting at 4 sites Fundación Santa Fe de Bogota · Bogotá, Bogota D.C. and 3 other locations · NCT07856212

• Targeting CLDN6-positive solid tumors with TJ037130

  A first-in-human study will test TJ037130 in adults with advanced solid tumors to see if it is safe, how it behaves in the body, and if it might work against the cancer.

  Recruiting Phase 1 TJ Biopharma Co., Ltd. · Shanghai, Shanghai Municipality · NCT07715747

• Autologous p95HER2 CAR-T Cells in HER2-Positive Cancers

  This study tests whether a patient’s own CAR-T cells targeting p95HER2 can be safely given to adults with HER2-positive metastatic cancers to see if it can help control tumors.

  Recruiting Phase 1 Vall d'Hebron Institute of Oncology · Barcelona, Catalonia and 1 other locations · NCT07593820

• PF-08634404 plus chemotherapy for advanced gastric, gastroesophageal junction, and esophageal adenocarcinoma

  This trial will test whether adding the experimental medicine PF-08634404 to chemotherapy helps adults with newly diagnosed, locally advanced or metastatic gastric, gastroesophageal junction, or esophageal adenocarcinoma compared with nivolumab plus chemotherapy.

  Recruiting at 90 sites Phase 2/3 Pfizer · Atascadero, California and 101 other locations · NCT07392892

• QL1706 (Iparomlimab + Tuvonralimab) with SOX chemotherapy for untreated advanced or metastatic gastric or gastroesophageal junction cancer

  This trial will test whether adding QL1706 (two immunotherapy drugs) to SOX chemotherapy helps people with previously untreated advanced or metastatic gastric or gastroesophageal junction cancer get a better tumor response.

  Recruiting Phase 2 Beijing Friendship Hospital · Beijing, Beijing Municipality · NCT07315854

• SHR2554 combined with other cancer medicines for advanced stomach or gastroesophageal junction adenocarcinoma

  This study will test if adding SHR2554 to other anti-cancer treatments helps people with advanced or metastatic gastric or gastroesophageal junction adenocarcinoma.

  Recruiting at 2 sites Phase 2 Jiangsu HengRui Medicine Co., Ltd. · Harbin, Heilongjiang and 1 other locations · NCT07102901

• Removing most of the stomach tumor after chemotherapy versus chemotherapy alone for limited metastatic stomach cancer

  This trial will test whether removing most of the stomach tumor after initial systemic therapy helps people with limited metastatic stomach cancer live longer than systemic therapy alone.

  Recruiting University Medical Center Ho Chi Minh City (UMC) · Ho Chi Minh City, Ho Chi Minh · NCT06768463

• Combination treatment for advanced HER2-positive gastric cancer

  This study is testing a new combination of treatments for people with advanced HER2-positive gastric cancer to see if it works better than the standard chemotherapy options.

  Recruiting at 16 sites Phase 2 Qilu Hospital of Shandong University · Zhengzhou, Henan and 19 other locations · NCT06730373

• Evaluating NKT3964 for Adults with Advanced Solid Tumors

  This study is testing a new drug called NKT3964 to see if it can safely help adults with advanced solid tumors, like ovarian or triple-negative breast cancer, after other treatments have failed.

  Recruiting at 17 sites Phase 1 NiKang Therapeutics, Inc. · Little Rock, Arkansas and 20 other locations · NCT06586957

• Combining radiotherapy and immunotherapy for limited metastatic gastric cancer

  This study is testing a new treatment that combines radiation, chemotherapy, and immunotherapy to see if it can help people with limited metastatic gastric cancer live longer and improve their health.

  Recruiting Phase 2 Fudan University · Shanghai · NCT06121700

• Evaluating liver embolization techniques for tumor management

  This study tests different liver embolization methods to see how well they help people with liver tumors live longer and maintain liver function while they continue their usual treatments.

  Recruiting IRCCS San Raffaele · Milan · NCT05714124

• Comparing Paclitaxel Infusion Durations in Cancer Patients with Low Muscle Mass

  This study is testing if giving paclitaxel over a longer time helps cancer patients with low muscle mass have better drug levels in their system compared to those with normal muscle mass.

  Recruiting Phase 4 University of Michigan Rogel Cancer Center · Ann Arbor, Michigan · NCT05183126

Related topics

Quick answers

How many Metastatic Gastric Cancer clinical trials are recruiting right now?

12, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 13 countries. The most sites are in China (6 trials), United States (3 trials), Italy (2 trials), Spain (2 trials), South Korea (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 4, Phase 1: 3, Phase 4: 1, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →